KISUNLA

This medication is infused into a vein. It is given by your care team in a hospital or clinic setting.
A special MedGuide will be given to you before each treatment. Be sure to read this information carefully each time.
Talk to your care team about the use of this medication in children. Special care may be needed.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.
NOTE: This medicine is only for you. Do not share this medicine with others.

Visit your care team for regular checks on your progress. Tell your care team if your symptoms do not start to get better or if they get worse.
This medication can cause a serious side effect called amyloid related imaging abnormalities (ARIA). ARIA can cause swelling or bleeding in the brain. Some people have a genetic risk factor that increases the risk of ARIA. Your care team may test you for this risk factor. The risk of bleeding in the brain is increased in people who take blood thinners. Talk to your care team if you take medications to prevent or treat blood clots. You will have imaging scans before and during your treatment to help your care team monitor for ARIA. Contact your care team right away if you have a severe headache, worsening confusion, dizziness, change in vision, nausea, trouble walking, or seizures.

Keep appointments for follow-up doses. It is important not to miss your dose. Call your care team if you are unable to keep an appointment.

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

This medication is given in a hospital or clinic. It will not be stored at home.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.